ArticleFrontiers in veterinary science2022

Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines.

Gennaro Altamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.